These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32774171)

  • 1. Potential interaction between lysophosphatidic acid and tumor-associated macrophages in ovarian carcinoma.
    Feng Y; Xiao M; Zhang Z; Cui R; Jiang X; Wang S; Bai H; Liu C; Zhang Z
    J Inflamm (Lond); 2020; 17():23. PubMed ID: 32774171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.
    Reinartz S; Lieber S; Pesek J; Brandt DT; Asafova A; Finkernagel F; Watzer B; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Konzer A; Graumann J; Grosse R; Worzfeld T; Müller-Brüsselbach S; Müller R
    Mol Oncol; 2019 Feb; 13(2):185-201. PubMed ID: 30353652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monocytes differentiate into tumor-associated macrophages upon SKOV3 cells coculture and/or lysophosphatidic acid stimulation.
    Feng Y; Xiao M; Cao G; Liu H; Li Y; Wang S; Zijtveld S; Delvoux B; Xanthoulea S; Romano A; Liu C; Zhang Z
    J Inflamm (Lond); 2022 Jul; 19(1):11. PubMed ID: 35842650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of thymoquinone on lysophosphatidic acid-induced oncogenic pathways in ovarian cancer cells.
    Ha JH; Jayaraman M; Radhakrishnan R; Gomathinayagam R; Yan M; Song YS; Isidoro C; Dhanasekaran DN
    J Tradit Complement Med; 2020 May; 10(3):207-216. PubMed ID: 32670815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor.
    Chou CH; Wei LH; Kuo ML; Huang YJ; Lai KP; Chen CA; Hsieh CY
    Carcinogenesis; 2005 Jan; 26(1):45-52. PubMed ID: 15471896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoproteomics Reveals Selective Regulation of Signaling Pathways by Lysophosphatidic Acid Species in Macrophages.
    Dietze R; Szymanski W; Ojasalu K; Finkernagel F; Nist A; Stiewe T; Graumann J; Müller R
    Cells; 2024 May; 13(10):. PubMed ID: 38786034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
    Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
    Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid converts monocytes into macrophages in both mice and humans.
    Ray R; Rai V
    Blood; 2017 Mar; 129(9):1177-1183. PubMed ID: 28069607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
    Sengupta S; Kim KS; Berk MP; Oates R; Escobar P; Belinson J; Li W; Lindner DJ; Williams B; Xu Y
    Oncogene; 2007 May; 26(20):2894-901. PubMed ID: 17130843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA
    Park J; Jang JH; Oh S; Kim M; Shin C; Jeong M; Heo K; Park JB; Kim SR; Oh YS
    Cell Signal; 2018 Apr; 44():138-147. PubMed ID: 29329782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
    Lee Z; Swaby RF; Liang Y; Yu S; Liu S; Lu KH; Bast RC; Mills GB; Fang X
    Cancer Res; 2006 Mar; 66(5):2740-8. PubMed ID: 16510595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lysophosphatidic acid as a potential target for treatment and molecular diagnosis of epithelial ovarian cancers].
    Tanyi J; Rigó J
    Orv Hetil; 2009 Jun; 150(24):1109-18. PubMed ID: 19739275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovatodiolide, isolated from Anisomeles indica, suppresses bladder carcinogenesis through suppression of mTOR/β-catenin/CDK6 and exosomal miR-21 derived from M2 tumor-associated macrophages.
    Wu ATH; Srivastava P; Yadav VK; Tzeng DTW; Iamsaard S; Su EC; Hsiao M; Liu MC
    Toxicol Appl Pharmacol; 2020 Aug; 401():115109. PubMed ID: 32544403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment.
    Schumann T; Adhikary T; Wortmann A; Finkernagel F; Lieber S; Schnitzer E; Legrand N; Schober Y; Nockher WA; Toth PM; Diederich WE; Nist A; Stiewe T; Wagner U; Reinartz S; Müller-Brüsselbach S; Müller R
    Oncotarget; 2015 May; 6(15):13416-33. PubMed ID: 25968567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidic Acid Stimulates the Proliferation of Ovarian Cancer Cells via the gep Proto-Oncogene Gα(12).
    Goldsmith ZG; Ha JH; Jayaraman M; Dhanasekaran DN
    Genes Cancer; 2011 May; 2(5):563-75. PubMed ID: 21901169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.
    Estrella VC; Eder AM; Liu S; Pustilnik TB; Tabassam FH; Claret FX; Gallick GE; Mills GB; Wiener JR
    Int J Oncol; 2007 Aug; 31(2):441-9. PubMed ID: 17611702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.
    Willier S; Butt E; Grunewald TG
    Biol Cell; 2013 Aug; 105(8):317-33. PubMed ID: 23611148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape.
    Montalbán Del Barrio I; Penski C; Schlahsa L; Stein RG; Diessner J; Wöckel A; Dietl J; Lutz MB; Mittelbronn M; Wischhusen J; Häusler SFM
    J Immunother Cancer; 2016; 4():49. PubMed ID: 27532024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.
    Fang X; Gaudette D; Furui T; Mao M; Estrella V; Eder A; Pustilnik T; Sasagawa T; Lapushin R; Yu S; Jaffe RB; Wiener JR; Erickson JR; Mills GB
    Ann N Y Acad Sci; 2000 Apr; 905():188-208. PubMed ID: 10818454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy.
    Gupta V; Yull F; Khabele D
    Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30274280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.